Risk stratification and clinical outcomes after surgical pulmonary valve replacement - 12/12/18
, William R. Miranda, MD a, Sameh M. Said, MD b, Sorin V. Pislaru, MD a, Patricia A. Pellikka, MD a, Barry A. Borlaug, MD a, Srikanth Kothapalli, MD a, Heidi M. Connolly, MD aAbstract |
Background |
To determine if RV volume was predictive of survival and cardiovascular adverse event (CAE) after pulmonary valve replacement (PVR).
Methods |
We reviewed the MACHD (Mayo Adult Congenital Heart Disease) database for patients with tetralogy of Fallot (TOF) undergoing PVR, 2000–2015. The patients were divided into quartiles based on RV end-diastolic volume index (RVEDVI); those in the lowest quartile (Group A, n = 46) and the top quartile (Group B, n = 42) were selected as the study cohort.
Results |
In comparison to Group A, Group B patients were older at time of PVR (28 ± 4 vs 33 ± 5 years, P = .011) and had larger RV volumes (RVEDVI 127 [117–138] mL/m2 vs 1 91 [179–208], P < .001; RVESVI 64 [57–73] mL/m2 vs 122 [103–136], P < .001). A total of 28 CAE occurred in 23 patients during 69 (33–94) months follow-up: death (n = 4), heart transplant listing (n = 1), initiation of palliative care (n = 1), heart failure hospitalization (n = 11), stroke (n = 2) and sustained ventricular tachycardia/aborted sudden cardiac death (n = 9). Survival was similar between Groups A and B (95% vs 91% at 10 years, P = .273) but freedom from CAE was significantly lower in Group B (67% vs 36% at 10 years, P = .002). Combination of RVESVI: >95 mL/m2 and tricuspid annular plane systolic excursion/RV systolic pressure (TAPSE/RVSP) <0.4 predicted CAE with sensitivity of 67% and specificity of 92%.
Conclusion |
Patients undergoing PVR at larger RV volumes had similar survival but more overall CAE. A larger study population with a longer follow-up will be required to determine if early PVR provides survival benefit in the long-term.
Le texte complet de cet article est disponible en PDF.Abbreviations : TOF, PR, PVR, CMRI, RVEDVI, RVESVI, FAC, TAPSE, RVSP, CAE, ROC, AUC
Plan
Vol 206
P. 105-112 - décembre 2018 Retour au numéro
Article précédent
- The East–West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohorts
- Robert W. Harrison, Vaishnavi Radhakrishnan, John C. Allen, Peter S. Lam, Dominic J. Allocco, Sandeep Brar, Martin Fahy, Zhen Zhang, Rebecca Fisher, Fumiaki Ikeno, Philippe Généreux, Takeshi Kimura, Minglei Liu, Weng Kit Lye, Hirofumi Nagai, Yuka Suzuki, Roseann White, Mitchell W. Krucoff
- The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians
- Kevin A. Schulman, Matan Dabora
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?